Rls Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 23 Days
About Rls Pharmaceuticals
Rls Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 January 2023 (Two years 23 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Akshay Mahendran, Kedar Deobhankar, and Swati Vitonde serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909PN2023PTC217784
-
Company No.
217784
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Jan 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Rls Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akshay Mahendran
|
Director | 09-Jan-2023 | Current |
|
Kedar Deobhankar
|
Director | 09-Jan-2023 | Current |
|
Swati Vitonde
|
Director | 09-Jan-2023 | Current |
Financial Performance of Rls Pharmaceuticals.
Enhance accessibility to Rls Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rls Pharmaceuticals?
Unlock access to Rls Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Ross Lifescience LimitedAkshay Mahendran, Kedar Deobhankar and 1 more are mutual person
-
Goodlife Industries LimitedAkshay Mahendran is a mutual person
-
Goodlife Investments LimitedAkshay Mahendran is a mutual person
-
Daiki Apparel Private LimitedAkshay Mahendran is a mutual person
-
Goodlife Fitness LlpAkshay Mahendran is a mutual person
-
Rls Household Insecticides Llp
Akshay Mahendran and Kedar Deobhankar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rls Pharmaceuticals?
Unlock and access historical data on people associated with Rls Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rls Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rls Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.